Supplementation with Curcuma longa reverses neurotoxic and behavioral damage in models of Alzheimer's disease: A systematic review.

CONCLUSION: The administration of curcumin in experimental models seems to be a promising approach in AD, even though it is suggested that additional studies must be conducted using distinct doses and through other routes of administration.
PMID: 29338678 [PubMed - as supplied by publisher]

Source: Current Neuropharmacology - January 16, 2018 Category: Drugs & Pharmacology Authors: da Costa IM, de Moura Freire MA, de Paiva Cavalcanti JRL, Pessoa de Araujo D, Norrara B, Rosa IMMM, Pereira de Azevedo E, Meneses do Rego AC, Filho IA, Guzen FP Tags: Curr Neuropharmacol Source Type: research